Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer - Contacts and Locations

Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer

This study is ongoing, but not recruiting participants.
Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00104793

Locations


Japan
	National Hospital Organization - Medical Center of Kure
	Hiroshima, Japan, 737-0023
	Gunma Cancer Center
	Gunma, Japan, 373-8550
	Osaka Kosei Nenkin Hospital
	Osaka, Japan, 553-0003
	Tokyo Medical and Dental University
	Tokyo, Japan, 113-8519

Japan, Hokkaido
	National Hospital Organization - Dohoku National Hospital
	Asahikawa, Hokkaido, Japan, 070-0901

Japan, Kanagawa
	Fujisawa City Hospital
	Fujisawa, Kanagawa, Japan, 251-8550

Japan, Okayama
	Kurashiki Central Hospital
	Kurashiki-shi, Okayama, Japan, 710-8602

Japan, Osaka
	National Hospital Organization - Osaka National Hospital
	Sakai, Osaka, Japan, 591-8555
	Osaka General Medical Center
	Osaka-shi, Osaka, Japan, 558-0056
	Takatsuki Red Cross Hospital
	Takatsuki, Osaka, Japan, 569-1096
	Yao Tokusyu-kai General Hospital
	Yao, Osaka, Japan, 561-0072

Sponsors and Collaborators

Japan Multinational Trial Organization

Investigators


Study Chair:	Tadashi Mio, MD	Kyoto University